Fosun Pharma Industrial Pte. Ltd. has disclosed the sale of a substantial portion of its equity shares in Gland Pharma Limited. The transaction, conducted via an open market sale on September 4, 2026, resulted in Fosun Pharma Industrial’s holding in Gland Pharma decreasing to 45.76% of the total share capital. This move represents a significant change in the shareholding structure of Gland Pharma.
Fosun Pharma Industrial Divests Gland Pharma Shares
Fosun Pharma Industrial Pte. Ltd. has announced the sale of a considerable stake in Gland Pharma Limited. This disclosure, made in accordance with SEBI regulations, details the transfer of equity shares that has altered Fosun Pharma Industrial’s ownership percentage in the target company.
Transaction Details
The sale occurred on September 4, 2026, and was executed through the Open Market. Prior to this transaction, Fosun Pharma Industrial held 51.76% of the total voting capital in Gland Pharma. Following the acquisition/sale, their holding has been reduced to 45.76%. The number of shares acquired/sold amounts to 98,97,000, representing 6.00% of the total share capital.
Share Capital Information
As of the date of acquisition/sale, the total diluted share/voting capital of Gland Pharma Limited stood at 166,262,312 equity shares. Fosun Pharma Industrial’s holding, after the sale, amounts to 7,54,96,894 equity shares, reflecting their current stake of 45.41% on a diluted basis.
Source: BSE
